USFDA, Pharma and Alembic
Alembic Pharma gets USFDA nod for Alcaftadine Ophthalmic Solution
Vadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application
Alembic Pharma Shares Jump on USFDA Approval for Lamotrigine Tablets
This approval enhances Alembic Pharma’s portfolio, which now totals 216 ANDAs from the USFDA, including 188 final and 28 tentative approvals.
USFDA gives nod to Alembic Pharma’s generic formulation to treat itchy eyes
Alembic has a cumulative total of 216 ANDA approvals (189 final approvals and 27 tentative approvals) from USFDA.
Alembic Pharma share price gains 5% after USFDA okays seizures drug
Alembic Pharma share price surged after the United States Food and Drug Administration (USFDA) gave final approval for Lamotrigine ExtendedRelease Tablets USP, 200 mg, 250 mg, and 300 mg.
Alembic Pharma secures USFDA nod for Seizure treatment drug Lamotrigine ER
Vadodara: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application
Alembic Pharma Gets US FDA Nod For Generic Medication To Treat Seizure
Lamotrigine extended-release tablets have an estimated market size of $163 million, as per data for twelve months ending June 2024, according to IQVIA.
Alembic Pharma shares jump 5% on final USFDA nod to Seizure treatment drug
This approval adds to Alembic Pharma's growing portfolio, which now includes 216 ANDA approvals from the USFDA, comprising 188 final approvals and 28 tentative approvals.
Alembic Pharma gets US FDA nod for antihistamine Alcaftadine ophthalmic solution
Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) Alcaftadine Ophthalmic Solution.
USDA gives nod to Alembic Pharma’s generic formulation to treat seizures
Alembic has a cumulative total of 216 ANDA approvals (188 final approvals and 28 tentative approvals) from USFDA.
Fortune India11h
₹5000 pm PM internship scheme rolls out; M&M, Max Life, Alembic evince interest
This is the first step in the direction of the budget announcement this year to provide internships to one crore youth in the ...
cnbctv1810h
M&M, Max Life, Alembic Pharma lead PM’s internship program as pilot project rolls out in four states
These companies have already listed 1,077 internship positions across sectors including auto, pharma, and agriculture.
Drug Store News3d
Alembic receives FDA nod for 2 generics
The FDA has approved Alembic's generic Albenza and generic Invega. Alembic has received The Food and Drug Administration’s ...
Dastak, Singapore's renowned Theatre and Film Festival, makes its Indian Debut in Vadodara
PNN Mumbai Maharashtra [India] October 4 WeCanDoIt a renowned theatre company from Singapore is proud to announce the Indian ...
Mahindra, Max Life Insurance, Alembic Pharma take lead in PM internship scheme
Mahindra Group, Max Life Insurance, and Alembic Pharmaceuticals are leading internships under a new central scheme, with ...